CIP
AVNS icon

Chartwell Investment Partners’s Avanos Medical AVNS Stock Holding History

Chartwell Investment Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-57,519
Closed -$2.58M – 436
2018
Q4 		$2.58M Sell
57,519
-34,819
-38% -$1.82M 0.09% 298
2018
Q3 		$6.33M Buy
92,338
+129
+0.1% +$8.3K 0.19% 178
2018
Q2 		$5.28M Buy
92,209
+43,719
+90% +$2.31M 0.16% 196
2018
Q1 		$2.23M Sell
48,490
-1,005
-2% -$47.7K 0.08% 279
2017
Q4 		$2.29M Sell
49,495
-3,043
-6% -$140K 0.08% 314
2017
Q3 		$2.37M Buy
+52,538
New +$2.24M 0.08% 302

Other funds holding AVNS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return